Evidence map›Paper›PMID 23712050›Full record

ArticleJournal of hepatology2013

Impaired liver regeneration in Ldlr-/- mice is associated with an altered hepatic profile of cytokines, growth factors, and lipids.

Montse Pauta, Noemi Rotllan, Frances Vales, Ana Fernandez-Hernando, Ryan M Allen, David A Ford, Montserrat Marí, Wladimiro Jiménez, Angel Baldán, Manuel Morales-Ruiz and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of hepatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Extracellular NADCommunications biology · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Montse PautaCentro Esther Koplowitz, IDIBAPS, CIBERehd, Barcelona, Spain.
Noemi Rotllan
Frances Vales
Ana Fernandez-Hernando
Ryan M Allen
David A Ford
Montserrat Marí
Wladimiro Jiménez
Angel Baldán
Manuel Morales-Ruiz
Carlos Fernández-Hernando
New York University · USConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESSaint Louis University · USCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ES

Funding

Control Sterol and Lipoprotein Homeostasis by miRNAR01HL107794 · NHLBI · SAINT LOUIS UNIVERSITY · PI BALDAN, ANGEL · 2011 to 2019
$3.3M
Plasmalogen-derived bioactive lipids in atherosclerosisR01HL074214 · NHLBI · SAINT LOUIS UNIVERSITY · PI FORD, DAVID A. · 2004 to 2014
$2.8M
Caveolin-1 in Lipoprotein Metabolism and Atherosclerosis.R01HL106063 · NHLBI · YALE UNIVERSITY · PI FERNANDEZ HERNANDO, CARLOS · 2011 to 2016
$2.5M
Role of microRNAs in lipid metabolism and cardiovascular diseaseR01HL107953 · NHLBI · YALE UNIVERSITY · PI FERNANDEZ HERNANDO, CARLOS · 2011 to 2016
$2.4M
Serum chlorinated lipids as predictors of cardiovascular risk in lupusR21HL098907 · NHLBI · SAINT LOUIS UNIVERSITY · PI FORD, DAVID A. · 2010 to 2011
$419k
TSQ QUANTUM ESI-MS SURVEYOR BUNDLE: RENAL, HEART, RETINAL, &LUNG DISEASESS10RR019232 · NCRR · SAINT LOUIS UNIVERSITY · PI FORD, DAVID A. · 2004 to 2004
$339k
NCRR NIH HHS S10 RR019232NHLBI NIH HHS R01 HL074214NHLBI NIH HHS R01 HL106063NHLBI NIH HHS R01 HL107794NHLBI NIH HHS R01 HL107953NHLBI NIH HHS R21 HL098907
6 · The paper itself

Abstract

BACKGROUND &

aimsIt is widely recognized that in the early stages of liver regeneration after partial hepatectomy, the hepatocytes accumulate a significant amount of lipids. The functional meaning of this transient steatosis and its effect on hepatocellular proliferation are not well defined. In addition, the basic mechanisms of this lipid accumulation are not well understood although some studies suggest the participation of the Low Density Lipoprotein Receptor (Ldlr).

methodsTo address these questions, we studied the process of liver regeneration in Ldlr null mice and wild type mice following partial hepatectomy.

resultsLdlr deficiency was associated with a significant decrease in serum albumin concentration, during early stages of liver regeneration, and a delayed hepatic regeneration. Remnant livers of Ldlr(-)(/)(-) showed a time-shifted expression of interleukin-6 (IL6) and a defective activation of tumor necrosis factor-α (TNFα) and hepatocyte growth factor (HGF) expression in early phases of liver regeneration. Unexpectedly, Ldlr(-)(/)(-) showed no significant differences in the content of lipid droplets after partial hepatectomy compared to wild type mice. However, lipidomic analysis of the regenerating liver from Ldlr(-)(/)(-) revealed a lipid profile compatible with liver quiescence: high content of cholesterol esters and ceramide, and low levels of phosphatidylcholine.

conclusionsLdlr deficiency is associated with significant changes in the hepatic lipidome that affect cytokine-growth factor signaling and impair liver regeneration. These results suggest that the analysis of the hepatic lipidome may help predict the success of liver regeneration in the clinical environment, specifically in the context of pre-existing liver steatosis.

Indexed as

Lipid MetabolismAnimalsCell Cycle CheckpointsCholesterolFatty LiverHepatectomyHepatocyte Growth FactorHypercholesterolemiaInterleukin-6LiverLiver RegenerationMaleMiceMice, Inbred C57BLMice, KnockoutReceptors, LDLCholesterolHepatocyte Growth FactorHGF protein, mouseInterleukin-6Receptors, LDLTumor Necrosis Factor-alphaLipidomicsLiver regenerationLow-density lipoprotein receptorPartial hepatectomySteatosis

Identifiers

PMID23712050
PMCPMC4145584
OpenAlexW1972725550

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.